ARCHIVES

Tumor Classification, Monoclonal Antibody Announcements Made

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988

In Brief: Georgetown, Theurer Form Collaboration; Hopkins To Develop Bladder Cancer Institute

June 6, 2014

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009